{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:10:44Z","timestamp":1778875844592,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"8764","license":[{"start":{"date-parts":[[1991,8,1]],"date-time":"1991-08-01T00:00:00Z","timestamp":681004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1991,8]]},"DOI":"10.1016\/0140-6736(91)91029-t","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T22:58:15Z","timestamp":1064271495000},"page":"399-403","source":"Crossref","is-referenced-by-count":168,"title":["Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"338","author":[{"given":"R.","family":"Pieters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"Huismans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.P.","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hahlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"van der Does-van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.R.","family":"Wering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0140-6736(91)91029-T_BIB1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0031-3955(16)36765-7","article-title":"Clinical pharmacology of cancer chemotherapy in children","volume":"36","author":"Evans","year":"1989","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/0140-6736(91)91029-T_BIB2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2141.1990.tb06323.x","article-title":"Drug sensitivity assays in leukemia and lymphoma","volume":"74","author":"Veerman","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0304-3835(88)90294-7","article-title":"Adaptation of a rapid automated tetrazolium based (MTT-)assay for chemosensitivity testing in childhood leukemia","volume":"41","author":"Pieters","year":"1988","journal-title":"Cancer Lett"},{"key":"10.1016\/0140-6736(91)91029-T_BIB4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0145-2126(88)90036-7","article-title":"Use of the MTT assay for rapid determination of chemosensitivity or human leukemic blast cells","volume":"12","author":"Campling","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/0140-6736(91)91029-T_BIB5","first-page":"472","article-title":"Anticancer drug sensitivity test using the short-term microplate culture and MTT dye reduction assay","volume":"14","author":"Hongo","year":"1987","journal-title":"Jpn J Cancer Chemother"},{"key":"10.1016\/0140-6736(91)91029-T_BIB6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hon.2900070405","article-title":"In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia","volume":"7","author":"Santini","year":"1989","journal-title":"Haematol Oncol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/bjc.1989.252","article-title":"Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia","volume":"60","author":"Sargent","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/0140-6736(91)91029-T_BIB8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.1989.tb06268.x","article-title":"Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay","volume":"71","author":"Twentyman","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/bjc.1989.44","article-title":"Comparison of a rapid automated tetrazolium based (MTT-)assay with a dye exclusion assay for chemosensitivity testing in childhood leukemia","volume":"59","author":"Pieters","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/0140-6736(91)91029-T_BIB10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0145-2126(90)90033-6","article-title":"Chemosensitivity testing of fresh human leukemic cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay","volume":"14","author":"Kirkpatrick","year":"1990","journal-title":"Leuk Res"},{"key":"10.1016\/0140-6736(91)91029-T_BIB11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/1097-0142(19900315)65:6<1263::AID-CNCR2820650602>3.0.CO;2-S","article-title":"An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia","volume":"65","author":"Hongo","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/0140-6736(91)91029-T_BIB12","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood.V76.11.2327.2327","article-title":"In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions","volume":"76","author":"Pieters","year":"1990","journal-title":"Blood"},{"key":"10.1016\/0140-6736(91)91029-T_BIB13","series-title":"Drug resistance in childhood leukemia","author":"Pieters","year":"1991"},{"key":"10.1016\/0140-6736(91)91029-T_BIB14","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1111\/j.1600-0609.1988.tb00887.x","article-title":"The immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia","volume":"41","author":"Van den Doel","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1016\/0140-6736(91)91029-T_BIB16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0305-7372(82)80041-8","article-title":"Clinical relevance of predictive tests for cancer chemotherapy","volume":"9","author":"Mattern","year":"1982","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/0140-6736(91)91029-T_BIB17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/bjc.1985.42","article-title":"Predictive chemosensitivity testing","volume":"51","author":"Twentyman","year":"1985","journal-title":"Br J Cancer"},{"key":"10.1016\/0140-6736(91)91029-T_BIB18","first-page":"615","article-title":"Clonogenic and nonclonogenic in vitro chemosensitivity assays","volume":"69","author":"Weisenthal","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0140-6736(91)91029-T_BIB19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jnci\/82.7.582","article-title":"Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacological drug exposures","volume":"85","author":"Kern","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/0140-6736(91)91029-T_BIB20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900030102","article-title":"In vitro determination of tumor chemosensitivity in hematological malignancies","volume":"3","author":"Bird","year":"1985","journal-title":"Hematol Oncol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-0609.1989.tb00323.x","article-title":"In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations","volume":"43","author":"Tidefelt","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB22","first-page":"1283","article-title":"Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms","volume":"70","author":"Weisenthal","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0140-6736(91)91029-T_BIB23","first-page":"4363","article-title":"In vitro and in vivo killing of acute lymphoblastric leukemia cells by l-asparaginase","volume":"49","author":"Asselin","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/0140-6736(91)91029-T_BIB24","series-title":"Acute leukemias: prognostic factors and treatment strategies","article-title":"Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis","author":"Riehm","year":"1987"},{"key":"10.1016\/0140-6736(91)91029-T_BIB25","first-page":"111","article-title":"Glucocortoid receptors and glucocorticoid resistance in human leukemia in vivo and in vitro","volume":"196","author":"Thompson","year":"1986"},{"key":"10.1016\/0140-6736(91)91029-T_BIB26","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.1989.7.12.1816","article-title":"Variable mercaptopurine metabolism and treatment outcome in childhood acute lymphohlastic leukaemia","volume":"7","author":"Lennard","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1987.4","article-title":"Thiopurine pharmacogenetics in leukaemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations","volume":"41","author":"Lennard","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/0140-6736(91)91029-T_BIB28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/bjc.1984.111","article-title":"Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization","volume":"49","author":"Lilleyman","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/0140-6736(91)91029-T_BIB29","first-page":"38","article-title":"Expression of the multidrug-resistance gene in childhood leukemia","volume":"4","author":"Tawa","year":"1990","journal-title":"Jpn J Pediatr Hematol"},{"key":"10.1016\/0140-6736(91)91029-T_BIB30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V74.4.1388.1388","article-title":"Expression of the mdr-1\/p-170 gene in patients with acute lymphoblastic leukemia","volume":"74","author":"Rothenberg","year":"1989","journal-title":"Blood"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:014067369191029T?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:014067369191029T?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T20:30:41Z","timestamp":1704918641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/014067369191029T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,8]]},"references-count":30,"journal-issue":{"issue":"8764","published-print":{"date-parts":[[1991,8]]}},"alternative-id":["014067369191029T"],"URL":"https:\/\/doi.org\/10.1016\/0140-6736(91)91029-t","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1991,8]]}}}